ended 30 September 2018 compared with the same period of the previous year as follows; 1. Overall operating results (Unit : 1,000 Baht) Q 3 ended 30 September % changes 2018 2017 Increase (decrease) Sales
the total revenues of 5,249 MTHB of which 5,216 MTHB earned from sales revenues. Sales revenues increased by 440 MTHB or 9.2% comparing to the same period of the year 2017. Such increase was mainly from
treatments went down 7.02 % due to the expenses of CMR decreased 0.25% and the separate financial increase 1.16% . 3. The net income decreased 25.59% (Separate financial statement : increased 5.79 %) due to
13.1% comparing to 2018 mostly from higher transportation costs, aligning with the increase of sales volume. 3. In the same period of last year, 93 MB loss on dilution on investment in an associate was
in Q3/2018 or 62.66% of sales. - Selling expenses in Q3/2019 amounted 275.21 million baht increased by 124.96 million baht or 83.17% compared to 150.25 million baht in Q3/2018 due to the increase of
asset size must share significant proportion to holding company and 2) holding company?s investment capital in other businesses (non-core business) must be less than 25% of holding company?s total asset
. ASEAN CIS to be offered must share similar substances with mutual funds allowed to establish in Thailand and be offered for sale through ASEAN CIS selling agent which is a licensed securities broker
share trading and from valuation of real estate with temporary price appreciation; ? Default risk: more discretion should be exercised when incurring debts, especially those for investment in
renowned international audit firms are invited to share their views and experience concerning current regulatory and oversight issues, challenges and impediments as well as directions of international
first six- month of the year 2017 ended June 30, 2017 as follows: Company’s Performance (unit: million Baht ) 2017 Percentage (%) 2016 Percentage (%) Change increase (decrease) (%) Total income and other